Related Experiment Video
Updated: May 31, 2026
05:57
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
Thujone corrects cholesterol and triglyceride profiles in diabetic rat model
Nour W Al-Haj Baddar1, Talal A Aburjai, Mutasem O Taha
1Department of Biological Sciences, Faculty of Science, University of Jordan, Amman 11942, Jordan.
Natural Product Research
|July 12, 2011
Summary
Thujone, a compound from Salvia sp., effectively corrected cholesterol and triglyceride levels in diabetic rats. This finding suggests thujone as a potential agent for managing diabetic lipid complications.
Area of Science:
- Phytochemistry
- Pharmacology
- Endocrinology
Background:
- Diabetes mellitus is a metabolic disorder characterized by hyperglycemia and dyslipidemia.
- Diabetic dyslipidemia involves elevated triglycerides and cholesterol, increasing cardiovascular risk.
- Salvia species are traditionally used for various medicinal purposes, with thujone being a major constituent.
Purpose of the Study:
- To investigate the effect of thujone on lipid profiles in a rat model of diabetes.
- To determine if thujone can normalize cholesterol and triglyceride levels in diabetic rats.
Main Methods:
- Oral administration of thujone at a dose of 5 mg/kg body weight to diabetic rats.
- Comparison of lipid profiles (cholesterol and triglycerides) between thujone-treated diabetic rats and untreated diabetic rats.
- Statistical analysis to determine the significance of observed changes (p ≤ 0.05).
Main Results:
- Thujone treatment significantly corrected cholesterol levels in diabetic rats.
- Thujone administration significantly adjusted triglyceride levels in diabetic rats.
- The lipid-modulating effects of thujone were statistically significant compared to the control group.
Conclusions:
- Thujone, a key component of Salvia sp., demonstrates significant lipid-correcting properties in diabetic rats.
- These findings support the potential of thujone as a therapeutic agent for managing dyslipidemia associated with diabetes.
- Further research into thujone's mechanism of action and clinical efficacy is warranted.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...